Cargando…
Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms
BACKGROUND: Myocardial infarction (MI) is a serious cardiovascular disease associated with myocardial ischemia/reperfusion (I/R) injury. Dexmedetomidine (Dex), an α2‐adrenoceptor agonist, has been reported to protect against I/R injury. We examined the cardioprotective effects of Dex on cardiomyocyt...
Autores principales: | Cai, Shunv, Liu, Yixing, Cheng, Yun, Yuan, Junbo, Fang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279977/ https://www.ncbi.nlm.nih.gov/pubmed/34882841 http://dx.doi.org/10.1002/jcla.24119 |
Ejemplares similares
-
Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes
por: Peng, Ke, et al.
Publicado: (2017) -
Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway
por: Shi, Xiaoqiao, et al.
Publicado: (2020) -
Dexmedetomidine Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury by Suppressing TLR4-MyD88-NF-κB Signaling
por: Gao, Jin-meng, et al.
Publicado: (2017) -
XuefuZhuyu decoction protected cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy
por: Shi, Xiaowen, et al.
Publicado: (2017) -
Moderate hypothermia induces protection against hypoxia/reoxygenation injury by enhancing SUMOylation in cardiomyocytes
por: Chen, Jinsheng, et al.
Publicado: (2020)